
Vision
To make Yongbang an internationally recognised brand for quality raw ingredients in the production of veterinary medicine.
1

R&D Focused
We are devoted in investing people and monetary funds into our R&D in order to create top quality and environmentally friendly APIs.
2

Strength
Apart from utilising some of the most technologically advanced equipment in our production workshops, laboratory and R&D centre, we also possess strong and reliable distribution networks with a large team of highly intelligent and motivated professionals.
3

Technical team
The company pays special attention to the recruitment of highly educated and knowledgeable pharmacists, as well as qualified technicians, and to the training of factory workers to ensure our products are meeting the highest quality standard.
4

Customer Service
Adhering to "customer first", we are here to satisfy all your personalised professional requirements.
5
About us
Inner Mongolia Yongbang Pharmaceutical Co., Ltd, established in August 2019 with a registered capital of 30 million RMB, is a high-tech enterprise focusing on the R&D, manufacture and sale of veterinary API.
The company is located in Yuanbaoshan Industrial Zone, Chifeng City, Inner Mongolia Autonomous Region. The project is on a total land size of 66,667 square meters, including two stages of developments.
The first stage, with an investment of 105 million RMB, was completed and put into operation in May 2021, including office building, production workshops, finished product warehouse, raw material warehouse, waste-water treatment facility and other supporting systems. With stage one workshops being fully operational, the company can achieve an annual turnover of 280 million RMB, whilst at the same time providing employment opportunities for more than 100 people.
The next stage development planning is well under way with the company looking to start Stage two in May 2023 and investing a further 145 million RMB in building five more production workshops and supporting facilities.

Product Center
2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester
Yongbang Sulfamonomethoxine Sodium
News
The products have responded well after being put into the market. At present, the output value and scale rank first in the country. The phase II hardware facilities have been completed, and the production of relevant raw materials is in full swing.